• Latest Posts

Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi

Did Bavarian Nordic cheat on its clinical results?

Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors

NASDAQ-listed Biotech from Boston shops cancer-treating antibodies in Italy

Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever

CureVac’s mRNA Therapy is Working Against Prostate Cancer


Kiadis launches its Cell-based Immunotherapies on European stock markets

Lilly Cooperates with Immunocore to Fight Skin Cancer

BioNTech and Siemens to build a new Production plant for Personalized Cancer Vaccines

Medigene plans to fund its T-cell program with €50 Millions

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

Polaris, a new Nordic leader in Immuno-Oncology